Health
How My Trip to Quit Sugar Quickly Became a Journey Into Hell
And from the more westerly of the two docks, it was possible to stare directly at the smaller, even more westerly, even more private dock reserved for the exclusive use of guests staying in the Vivamayr villa (which goes for 3,750 euros per night). My fellow regular guests and I squinted at the private villa dock and tried to discern the facial characteristics, or even the age, of the woman we saw there. (Impossible.) Constantly, people were eyeing one another to see if anyone was a celebrity. As nice and as expensive as Vivamayr was, just about everyone knew of somewhere even nicer and even more expensive, where even wealthier people could pay money for similar services; I overheard so much talk of such places that I eventually found myself thinking of Vivamayr as their rundown, dumpy cousin. Was this, I wondered, the key to Vivamayr’s success? Can the ultrawealthy be convinced of the program’s virtue only if their destination is, in some way, less than ideal?
When I’d chronicled my relentless pursuit of sweetness for my Vivamayr doctor, her eyes had sparkled like sanding sugar on grocery-store cookies cut in seasonal shapes. “I have something in mind,” she said at our first meeting: “Functional MyoDiagnostic” testing for “food intolerances.” I had no idea what the hell that was; sounded great.
On the appointed afternoon, I climbed steep sunlit stairs to her office. She bade me lie down on an exam table. I was to use my thigh muscles to move my knee toward my head, overpowering gentle pressure from her as she pushed the knee in the opposite direction. I moved it easily. She began tapping teensy smidgens of substances onto my tongue with the aid of a wooden depressor. After each deposit of crumbs, I was instructed to repeat the knee-to-head maneuver. If my tongue encountered a substance my body “does not like,” the doctor said, my muscles would get weaker for up to 20 seconds, before recovering. In this way, she would identify allergies, weaknesses and deficiencies in my diet. I moved my knee without any trouble until she placed a fine white powder onto my tongue; suddenly, I could barely push against her. “That’s actually what I thought,” she said.
My muscles had reacted poorly to a few crumbs of yeast, the doctor reported, which meant that my craving for sweets was caused by a fungal infection in my gut. The microorganisms of the infection, she explained, lived on sweets, and I was feeding them constantly. “We have to starve it out,” the doctor said, of the thing growing inside me. “You know what it means: No sweets. No yeast.” I would also have to take medication. I was staggered. What I had believed was my own preference was apparently the insatiable appetite of a foreign invader. “What would cause this?” I asked. The doctor believed I had had this infection “for a very long time”; perhaps it grew out of an antibiotic I took at some point in childhood, she said. She was “absolutely astonished,” that my body had not been further ravaged.
I was not ready to give up sweets just because I had lost control of my person decades ago to some alien fungus that had hijacked my mind in its relentless pursuit of sugar. Because I was functioning well with the infection, I wondered aloud, wasn’t there a risk that, if I tried to eradicate it, my body chemistry would fall out of whack? The only risk, the doctor said, was in continuing to allow it to flourish unchecked. “It might interfere with your intestines” if I kept it “too long,” she said. “It might really harm your bowels. And your sugar craving will never end.” If I successfully eradicated the infection, she added, my digestion, which was already good, might, in some way, become even better.
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
NEWYou can now listen to Fox News articles!
A cure for cancer could be on the horizon in the next decade, according to experts.
During the WSJ Leadership Institute CEO Summit in London last week, Johnson & Johnson Chairman and CEO Joaquin Duato reflected on the pharmaceutical company’s projections on the future of cancer treatment.
In the next 10 years, the goal is to “try to eliminate cancer,” Duato shared.
NEW CANCER VACCINE DELIVERS STUNNING RESULT AGAINST ONE OF THE DEADLIEST SKIN CANCERS
“That’s a high goal, and we are already making significant progress in certain cancers,” he said.
Duato used multiple myeloma as an example, noting that the life expectancy is currently 10 years, when it was previously “only single years.”
Joaquin Duato, chairman and CEO of Johnson and Johnson, speaks at the Punchbowl News Conference at Union Station on March 10, 2026, in Washington, DC. (Heather Diehl/Getty Images)
“We have treatments now that utilize your own immune system to attack the cancer,” he said at the summit. “For patients who were already going into hospice, so they didn’t have any other alternative, they are [at] more than five years, with a single administration, in remission. That [is] spectacular.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“When patients see that, they cannot believe that because they have been coming to the hospital every week [for] a decade, having multiple therapies.”
The goal is to “try to eliminate cancer” in the next 10 years, the pharmaceutical executive said. (iStock)
According to Duato, Johnson & Johnson is working to understand the biology of cancer growth and to formulate new technologies to address it.
“It’s realistic to believe that we are going to cure certain cancers, and some others we’re going to turn into chronic diseases,” he predicted.
CLICK HERE FOR MORE HEALTH STORIES
“Cancer is an important thing – I cannot think about anybody who has not been touched by cancer,” he went on. “But there are many other opportunities for us to actually advance science, to address very important social problems.”
Duato called out dementia as another “important problem” in need of a solution.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
He predicted that life expectancy, which has risen steadily over the past century, will continue to increase as longevity technologies and solutions advance, improving quality of life along the way.
Duato commented that J&J has been optimistic about the role artificial intelligence will play in the future of healthcare, calling it a “force multiplier.”
Biomarkers and AI can help with the earlier diagnosis of cancer, as well as a more advanced and personalized approach to surgery, a doctor noted. (iStock)
Fox News senior medical analyst Dr. Marc Siegel agreed with Duato’s outlook on the future of cancer care, noting that certain cancers will turn into chronic diseases while others will find outright cures.
“Advances [will be] based on the use of AI to help guide targeted treatments with expanding knowledge of cancer mutations and how to target them,” he predicted, speaking to Fox News Digital.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Siegel added that biomarkers and AI can help with earlier diagnoses, as well as a more advanced and personalized approach to surgery.
J&J recently acquired Firefly Bio, a biotech firm that produces drugs that enter cancer cells to “target certain proteins that contain difficult to treat gene mutations,” the doctor added.
NEWYou can now listen to Fox News articles!
Among those taking GLP-1 medications for weight loss, exercise rates are decreasing, according to new research.
The study, set to be presented at ENDO 2026 (the Endocrine Society’s annual meeting) in Chicago this week, found that adults with obesity who lost weight with a GLP-1, such as Ozempic or Wegovy, “significantly reduced” their physical activity.
In an Endocrine Society press release, study lead Sajana Maharjan, MD, of HSHS St. John’s Hospital in Springfield, Illinois, noted that GLP-1 drugs like semaglutide, liraglutide, dulaglutide and tirzepatide reduce both fat and lean muscle mass.
‘WILD WEST’ PEPTIDE CRAZE SURGES BEYOND GLP-1S AS FDA FACES PRESSURE TO EASE ACCESS
This means physical activity is “essential for preserving strength and long-term health,” she said.
The study, reportedly the first of its kind, considered data from a National Institutes of Health research program that linked participant records with fitness tracker activity.
Researchers analyzed data from 753 people with obesity who initiated a GLP-1 medication. The cohort was mostly female, at a mean age of 52.7 years.
Among participants, the average number of steps decreased from 5,047 to 4,487 per day. (iStock)
Comparing activity in participants before and after beginning treatment, the average number of steps decreased from 5,047 to 4,487 per day. Moderate-to-vigorous physical activity fell from 28 to 22 minutes per day, the study found.
The largest declines were observed in men and in those with joint or muscle pain. Other factors like age, heart failure or prior stroke did not change results.
OZEMPIC ‘MICRODOSING’ IS THE NEW WEIGHT-LOSS TREND: SHOULD YOU TRY IT?
Although many people might assume that losing weight with these medications would lead to increased physical activity, the study found no evidence that it did, according to Maharjan.
“The findings in our study reinforce that exercise cannot be optional for people taking these medications,” he said. “People need targeted interventions that encourage physical activity alongside medication for obesity.”
FITNESS EXPERT REVEALS SIMPLE RULE TO GET IN SHAPE WITHOUT DREADING THE GYM: ‘JUST MOVE’
The study was retrospective and observational, meaning it could only display an association, not a direct cause. The participants were also mostly middle-aged women, which could limit the scope of who is most impacted, the researchers noted.
Other factors that were not measured include exercise habits before starting treatment, motivation levels and guidance from a physician.
Although many people might assume that losing weight with these medications would lead to increased physical activity, the study found no evidence that it did, according to the researcher. (iStock)
Dr. Peter Balazs MD, a hormone and weight-loss specialist practicing in New York and New Jersey, echoed in an interview with Fox News Digital that weight loss does not automatically lead to increased mobility or greater motivation to exercise.
“In fact, being in a calorie deficit can cause the body to conserve energy, resulting in a lower metabolic rate,” he said.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
“Additionally, side effects of weight-loss medications, such as nausea, fatigue or gastrointestinal discomfort, may further reduce a person’s ability or desire to be physically active,” the expert added.
For GLP-1 users, Balazs stressed that exercise “is not optional.” Patients must incorporate resistance training and regular daily movement, like walking, into their routine to “preserve lean muscle mass, maintain metabolic health and support long-term weight management,” he advised.
Exercise supports bone and joint health and enhances cardiovascular fitness, the researcher said. (iStock)
“Exercise plays a critical role during weight loss,” Balazs said. “Without adequate physical activity, a significant portion of weight loss may come from muscle rather than fat.”
The expert noted that there is not a one-size-fits-all approach, as the timing, intensity and type of workout should be individualized based on a person’s fitness level, health status and body composition.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
“This is particularly important for patients with a high BMI who may have mobility limitations or lower baseline fitness levels,” Balazs said. “It’s important to consider injury risk, long-term adherence and the potential for early burnout.”
Contrasting views
Board-certified internist and longevity expert Dr. Amanda Kahn said she disagrees with this study’s conclusions, as they do not reflect what she is seeing in her own clinical practice.
“Weight loss often serves as the impetus that motivates patients to become more physically active and more engaged in their overall health,” the New York-based expert told Fox News Digital.
Successful treatment requires regular follow-up, monitoring of protein intake, monthly weight checks, quarterly body composition scans and routine laboratory testing, an expert advised. (iStock)
“The success of GLP-1 therapy is directly tied to the expertise of the provider,” she went on. “When these medications are prescribed thoughtfully – with attention to nutrition, resistance training, body composition and laboratory monitoring – they can help patients lose weight while becoming healthier, stronger and more motivated to exercise.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Kahn, a peptide prescriber, does not recommend simply prescribing a GLP-1 medication and allowing the patient to “self-manage.”
“In my practice, if a patient is unable to exercise, is not meeting protein goals or shows concerning muscle loss on body composition analysis, I will often hold or adjust the medication – because preserving strength, function and metabolic health is just as important as weight loss,” she said.
CLICK HERE FOR MORE HEALTH STORIES
If a GLP-1 patient becomes too fatigued to exercise, develops nutritional deficiencies or loses excessive muscle mass, Kahn warned that this reflects a “monitoring problem” rather than a medication problem, as these medications “require close clinical oversight.”
-
Oregon1 minute agoDeadly officer-involved shooting on Oregon Coast under investigation
-
Pennsylvania8 minutes agoShowers Thursday morning, warm and gusty for the afternoon
-
Rhode Island11 minutes agoCumberland Man Charged With DUI After Crash in Lincoln: Cops
-
South-Carolina16 minutes agoSouth Carolina Lottery Powerball, Pick 3 results for June 17, 2026
-
South Dakota23 minutes ago
SD Lottery Powerball, Lotto America winning numbers for June 17, 2026
-
Tennessee26 minutes agoTennessee man sentenced to 24 years for fentanyl distribution conspiracy
-
Texas31 minutes agoDPS trooper killed in Texas Panhandle crash, agency says
-
Utah38 minutes agoUtah first lady Abby Cox optimistic about legislative moves to strengthen child literacy
